TY - JOUR
T1 - Respiratory Vaccines in Older Adults
T2 - A Bibliometric Analysis and Future Research Agenda
AU - Parodi, Jose F.
AU - Runzer-Colmenares, Fernando
AU - Cano-Gutiérrez, Carlos
AU - Dinamarca-Montecinos, José Luis
AU - Torre, Patricio Bendía Gomez de La
AU - Villas Boas, Paulo Fortes
AU - Flores-Cohaila, Javier
AU - Urrunaga-Pastor, Diego
AU - Gutiérrez-Robledo, Luis Miguel
N1 - Publisher Copyright:
© 2025 by the authors.
PY - 2025/3
Y1 - 2025/3
N2 - Background/Objectives: Respiratory infections impact older adults due to immunosenescence and comorbidities, resulting in increased healthcare costs and mortality. While vaccination is a critical preventive measure, research on respiratory vaccines in older adults in Latin America and the Caribbean (LAC) remains underexplored. This study aims to map the research landscape and identify emerging themes to guide future studies. Methods: A bibliometric analysis was conducted using the Web of Science database, focusing on publications up to 2023 related to respiratory vaccines in LAC’s older adult population. PRISMA-ScR guidelines were followed for data extraction and analysis, with performance metrics and scientometric mapping conducted using Biblioshiny 4.1 and VOSviewer. Results: Ninety-nine studies spanning forty-one journals and 575 authors were included. Brazil contributed 70% of publications, followed by Mexico and Argentina. Influenza and pneumococcal vaccines were the most studied, focusing on coverage, acceptance, and cost-effectiveness. Emerging themes included COVID-19 vaccine effectiveness and vaccination-associated factors. Brazil was identified as the primary hub for collaboration across the region, while other countries made limited contributions. Conclusions: The findings highlight disparities in research output, with Brazil dominating and significant gaps in other LAC countries. Future research should prioritize genomic studies, vaccine efficacy in comorbid populations, and adaptive immunization strategies. Building research capacity and fostering international collaborations are essential for improving vaccination outcomes in older adults across LAC.
AB - Background/Objectives: Respiratory infections impact older adults due to immunosenescence and comorbidities, resulting in increased healthcare costs and mortality. While vaccination is a critical preventive measure, research on respiratory vaccines in older adults in Latin America and the Caribbean (LAC) remains underexplored. This study aims to map the research landscape and identify emerging themes to guide future studies. Methods: A bibliometric analysis was conducted using the Web of Science database, focusing on publications up to 2023 related to respiratory vaccines in LAC’s older adult population. PRISMA-ScR guidelines were followed for data extraction and analysis, with performance metrics and scientometric mapping conducted using Biblioshiny 4.1 and VOSviewer. Results: Ninety-nine studies spanning forty-one journals and 575 authors were included. Brazil contributed 70% of publications, followed by Mexico and Argentina. Influenza and pneumococcal vaccines were the most studied, focusing on coverage, acceptance, and cost-effectiveness. Emerging themes included COVID-19 vaccine effectiveness and vaccination-associated factors. Brazil was identified as the primary hub for collaboration across the region, while other countries made limited contributions. Conclusions: The findings highlight disparities in research output, with Brazil dominating and significant gaps in other LAC countries. Future research should prioritize genomic studies, vaccine efficacy in comorbid populations, and adaptive immunization strategies. Building research capacity and fostering international collaborations are essential for improving vaccination outcomes in older adults across LAC.
KW - bibliometric analysis
KW - COVID-19
KW - influenza
KW - Latin America
KW - older adults
KW - pneumococcal
KW - respiratory vaccines
UR - http://www.scopus.com/inward/record.url?scp=105001110938&partnerID=8YFLogxK
U2 - 10.3390/vaccines13030240
DO - 10.3390/vaccines13030240
M3 - Review article
AN - SCOPUS:105001110938
SN - 2076-393X
VL - 13
JO - Vaccines
JF - Vaccines
IS - 3
M1 - 240
ER -